Showing results (1571-1580 of 3,156) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|October 17, 2017
Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastomaPhilipp Kickingereder, Ulf Neuberger, David Bonekamp, et al.
Neuro-Oncology|June 15, 2026
Multi-sampling allows intra-tumoral heterogeneity querying and vulnerability profiling in glioblastomaDiogo Moniz Garcia, Wan-Hsin Lin, Daniel P Wickland, et al.
Neuro-Oncology|February 6, 2013
Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade gliomaPeter S LaViolette, Alex D Cohen, Melissa A Prah, et al.
Neuro-Oncology|June 30, 2026
The clinical and molecular landscape of thalamic gliomaLinpeng Zhang, Hesong Wang, Guangrui Huang, et al.
Neuro-Oncology|June 29, 2026
Tumor-Targeted pan-RAS Inhibition as a Novel Biologic Therapy for Diffuse Midline GliomaStefanie-Grace Sbergio, Huazhu Liang, Lucy Chen, et al.
Neuro-Oncology|May 15, 2015
Decreased affinity for efflux transporters increases brain penetrance and molecular targeting of a PI3K/mTOR inhibitor in a mouse model of glioblastomaChani M Becker, Rajneet K Oberoi, Stephan J McFarren, et al.
Neuro-Oncology|June 14, 2019
Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurementKen Chang, Andrew L Beers, Harrison X Bai, et al.
Neuro-Oncology|September 1, 2016
Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimenSarah J Nelson, Achuta K Kadambi, Ilwoo Park, et al.
Neuro-Oncology|June 19, 2026
Tumor-associated epilepsy at diagnosis in glioblastoma patients reveals an inflammatory molecular signature and is associated with better overall survivalLilyana Dimova, Jenny Stritzelberger, Diyan Dimov, et al.
Neuro-Oncology|April 12, 2012
Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastomaElana S Tykocinski, Ryan A Grant, Gurpreet S Kapoor, et al.
Pageof 316